Tremor
Tremor
Explore linked clinical trials. Standard reference: MESH:M002186940 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Wearable for Assessing Tremor and Continuous Health in Parkinson's Disease and Essential Tremor | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2026-10-09 | NCT07787299 | |
| A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus) | Acid-Base Imbalance, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Ear Diseases, MELAS syndrome, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Tremor, acidosis disorder, anxiety disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dystonic disorder, eye disorder, headache disorder, hearing disorder, hearing loss disorder, hereditary disease, hypnic headache, inborn errors of metabolism, inborn mitochondrial metabolism disorder, inborn mitochondrial myopathy, lactic acidosis, metabolic disease, migraine disorder, mitochondrial encephalomyopathy, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, otorhinolaryngologic disease, psychiatric disorder, vascular disorder, vision disorder, visual epilepsy | Not yet recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT06792500 | |
| First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD) | Cognition Disorders, Cognitive Dysfunction, Dyskinesias, Muscle Hypertonia, Muscle Rigidity, Neurologic Manifestations, Neuromuscular Manifestations, Parasomnias, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, mood disorder, movement disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, sleep-wake disorder, synucleinopathy | Recruiting | Phase 1 | 2026-09-21 | NCT07216066 | |
| Natural History Protocol for Movement Disorders | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2026-09-18 | NCT05413291 | |
| Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, essential tremor, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2026-09-16 | NCT01734122 | |
| Comparison of Benzhexol and Procyclidine for Tremor in Tremor-Predominant Parkinson's Disease | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not applicable | 2026-09-14 | NCT07810296 | |
| A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 | 2026-09-11 | NCT07804615 | |
| Connectomic Guided DBS for Parkinson's Disease | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Enrolling by invitation | Not applicable | 2026-09-03 | NCT06618157 | |
| Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not applicable | 2026-09-01 | NCT06993571 | |
| Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease | Cough, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sialorrhea, Signs and Symptoms, Signs and Symptoms, Respiratory, Stomatognathic Diseases, Tremor, Xerostomia, basal ganglia disorder, brain disorder, central nervous system disorder, communication disorder, laryngeal disorder, mouth disorder, movement disorder, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, otorhinolaryngologic disease, parkinsonian disorder, psychiatric disorder, respiratory system disorder, salivary gland disorder, synucleinopathy, voice disorders | Active, not recruiting | Not applicable | 2026-08-07 | NCT07588191 | |
| Deep Brain Stimulation of the Deep Cerebellar Nuclei for Refractory Tremor | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Recruiting | Phase 1 | 2026-07-10 | NCT07049003 | |
| Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Not applicable | 2026-06-10 | NCT07384442 | |
| Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients | Dyskinesias, Dyssomnias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, Tremor, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Phase 4 | 2026-05-28 | NCT06751992 | |
| Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Recruiting | Early phase 1 | 2026-05-20 | NCT07599592 | |
| Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Recruiting | Not stated | 2026-05-08 | NCT06293638 | |
| Closed-loop TMS for Tremor | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, essential tremor, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not applicable | 2026-05-07 | NCT07574164 | |
| Gluten Challenge in Celiac Disease - Which Formulation of Gluten Gives the Best Response? | Digestive System Diseases, Dyskinesias, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, celiac disease, digestive system disorder, intestinal disorder, malabsorption syndrome, metabolic disease, nervous system disorder | Recruiting | Not applicable | 2026-04-17 | NCT07039773 | |
| CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, nervous system disorder | Recruiting | Phase 2 / Phase 3 | 2026-04-13 | NCT03769298 | |
| Effects of Stimulation Patterns of Deep Brain Stimulation | CNS demyelinating autoimmune disease, Dyskinesias, Hypokinesia, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain disorder, central nervous system disorder, demyelinating disease, dystonic disorder, essential tremor, immune system disorder, movement disorder, multiple sclerosis, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Enrolling by invitation | Not applicable | 2026-04-09 | NCT02553525 | |
| Neurosurgical Outcome Network | Aneurysm, Arterial Occlusive Diseases, Cardiovascular Abnormalities, Chiari malformation type I, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniocerebral Trauma, Craniofacial Pain, Drug Resistant Epilepsy, Dyskinesias, Facial Pain, Hematoma, Hematoma, Epidural, Spinal, Hematoma, Subdural, Hemorrhage, Intracranial Hemorrhage, Traumatic, Intracranial Hemorrhages, Moyamoya disease, Muscle Hypertonia, Muscle Spasticity, Neurologic Manifestations, Neuromuscular Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stomatognathic Diseases, Tremor, anxiety disorder, arteriovenous hemangioma/malformation, brain disorder, cardiovascular disorder, carotid artery disorder, central nervous system disorder, cerebral arterial disease, cerebrovascular disorder, cranial nerve neuropathy, depressive disorder, dystonic disorder, epilepsy, facial nerve disorder, facial neuralgia, hydrocephalus, injury, intracranial arterial disease, mouth disorder, movement disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, nervous system injury, neuralgia, neuromuscular disease, normal pressure hydrocephalus, obsessive-compulsive disorder, peripheral nervous system disorder, psychiatric disorder, subarachnoid hemorrhage, trigeminal nerve disorder, trigeminal neuralgia, vascular disorder, vascular malformation | Recruiting | Not stated | 2026-03-30 | NCT06724029 | |
| ET Stigma Response to Tremor Suppression | Action Tremor, Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Recruiting | Not stated | 2026-02-24 | NCT07430761 | |
| Detection of Internal Tremors by Oscillometry in Parkinson's Patient | Dyskinesias, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not applicable | 2026-02-17 | NCT06885541 | |
| Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms | Dyskinesias, Hypokinesia, Muscle Hypertonia, Muscle Rigidity, Neurologic Manifestations, Neuromuscular Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 1 / Phase 2 | 2026-01-27 | NCT07182058 | |
| Responsive Deep Brain Stimulator for Essential Tremor | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, central nervous system disorder, essential tremor, movement disorder, nervous system disorder | Active, not recruiting | Not applicable | 2026-01-09 | NCT02649166 | |
| Abbott DBS Post-Market Study of Outcomes for Indications Over Time | Dyskinesias, Dystonia, Primary, Dystonia, Secondary, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, dystonic disorder, essential tremor, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2026-01-08 | NCT04071847 |